Statistics
Publications
16
Citations
856
H-Index
14
Active since
2014
Kun Li is an author at East China Normal University specializing in oncology, medicine, and molecular oncology.
Publications per year
2014–2024
16
16
FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway
Kun Li, Qunfeng Guo, Jun Yang et al. · Oncotarget · 2016 · 53 citations · Full text
Medicine, Cancer Biology, Oncology +17
BCL6 confers KRAS-mutant non–small-cell lung cancer resistance to BET inhibitors
Jiawei Guo, Yanan Liu, Jing Lv et al. · Journal of Clinical Investigation · 2021 · 51 citations · Full text
Medicine, Cancer Biology, Oncology +15
1–5 of 16